INFLUENZA VIRUS-BASED ISOLATED RECOMBINANT VIRUS
The present invention relates to the fields of biotechnology, immunology, virology, genetics, and molecular biology. More specifically, the present invention relates to an isolated nucleic acid encoding a recombinant polypeptide for increasing the titer of antibodies to influenza virus (variants), an influenza virus-based recombinant virus for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases, a pharmaceutical composition and a vaccine that include the above influenza virus-based recombinant virus, as well as their use for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 19. Jan. Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
RUDENKO LARISA GEORGIEVNA [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-01-19, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 |
|---|
| Patentnummer: |
WO2023287324 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA00219726X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA00219726X | ||
| 003 | DE-627 | ||
| 005 | 20240409143054.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240327s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA00219726X | ||
| 035 | |a (EPA)WO2023287324 | ||
| 035 | |a (EPA)84919538 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a RUDENKO LARISA GEORGIEVNA |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a INFLUENZA VIRUS-BASED ISOLATED RECOMBINANT VIRUS |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-01-19, Last update posted on www.tib.eu: 2024-04-03, Last updated: 2024-04-09 | ||
| 520 | |a The present invention relates to the fields of biotechnology, immunology, virology, genetics, and molecular biology. More specifically, the present invention relates to an isolated nucleic acid encoding a recombinant polypeptide for increasing the titer of antibodies to influenza virus (variants), an influenza virus-based recombinant virus for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases, a pharmaceutical composition and a vaccine that include the above influenza virus-based recombinant virus, as well as their use for inducing specific immunity to influenza virus and/or preventing influenza virus-related diseases. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a ISAKOVA-SIVAK IRINA NIKOLAYEVNA |e verfasserin |4 aut | |
| 700 | 0 | |a STEPANOVA EKATERINA ALEKSEEVNA |e verfasserin |4 aut | |
| 700 | 0 | |a MATIUSHENKO VIKTORIIA ARKADIENVA |e verfasserin |4 aut | |
| 700 | 0 | |a NISKANEN SERGEI ANDREEVICH |e verfasserin |4 aut | |
| 700 | 0 | |a NETEREBSKII BOGDAN OLEGOVICH |e verfasserin |4 aut | |
| 700 | 0 | |a VLADIMIROVA ANNA KONSTANTINOVNA |e verfasserin |4 aut | |
| 700 | 0 | |a IAKOVLEV PAVEL ANDREEVICH |e verfasserin |4 aut | |
| 700 | 0 | |a USTIUGOV IAKOV IUREVICH |e verfasserin |4 aut | |
| 700 | 0 | |a SHEUDZHEN TIMUR MUGDINOVICH |e verfasserin |4 aut | |
| 700 | 0 | |a DORONIN ALEKSANDR NIKOLAEVICH |e verfasserin |4 aut | |
| 700 | 0 | |a OSTROUKHOVA TATIANA UREVNA |e verfasserin |4 aut | |
| 700 | 0 | |a ALEKSANDROV ALEKSEI ALEKSANDROVICH |e verfasserin |4 aut | |
| 700 | 0 | |a MOROZOV DMITRY VALENTINOVICH |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 19. Jan. |
| 773 | 1 | 8 | |g year:2023 |g day:19 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/84919538/publication/WO2023287324A1?q=WO2023287324 |m X:VERLAG |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 19 |c 01 | ||